Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ankyra Therapeutics and Jenga Biosciences are pleased to announce today an exclusive license agreement to develop and commercialize…
BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced…
Medidata Rave Companion, the industry’s first data entry companion, is recognized for improving the speed and accuracy of information capture…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2024” conference has been added to ResearchAndMarkets.com’s offering. The Global Clinical Trials Connect 2024…
DUBLIN–(BUSINESS WIRE)–The “Digi-Tech Pharma & AI 2024” conference has been added to ResearchAndMarkets.com’s offering. The 7th Annual Digi-Tech Pharma &…
BERWYN, Pa.–(BUSINESS WIRE)–#earnings—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain…
Study to evaluate TX45 impact on cardiopulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension, a patient population in urgent…
– Cash runway through Q1 2026 following announcement of a $175 million term loan facility with Hercules Capital – –…
Financing and Reinforcement of Board of Directors Builds Momentum in Readiness for the Initiation of the IDE Pivotal Trial AACHEN,…
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its…